98 related articles for article (PubMed ID: 35073472)
1. Significant cognitive impairment likely associated with COVID-19 infection with relatively nonsevere symptoms.
Reeves RR; Willoughby SG
J Osteopath Med; 2022 Jan; 122(3):119-123. PubMed ID: 35073472
[TBL] [Abstract][Full Text] [Related]
2. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline.
Pyne JD; Brickman AM
Neurodegener Dis; 2021; 21(1-2):1-23. PubMed ID: 34348321
[TBL] [Abstract][Full Text] [Related]
3. Delirium and Cognitive Impairment as Predisposing Factors of COVID-19 Infection in Neuropsychiatric Patients: A Narrative Review.
Fabrazzo M; Russo A; Camerlengo A; Tucci C; Luciano M; De Santis V; Perris F; Catapano F; Coppola N
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833462
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2-Associated Acute Hemorrhagic, Necrotizing Encephalitis (AHNE) Presenting with Cognitive Impairment in a 44-Year-Old Woman without Comorbidities: A Case Report.
Ghosh R; Dubey S; Finsterer J; Chatterjee S; Ray BK
Am J Case Rep; 2020 Aug; 21():e925641. PubMed ID: 32799213
[TBL] [Abstract][Full Text] [Related]
5. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.
Stefano GB; Büttiker P; Weissenberger S; Martin A; Ptacek R; Kream RM
Med Sci Monit; 2021 May; 27():e933015. PubMed ID: 34016942
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.
Hosp JA; Dressing A; Blazhenets G; Bormann T; Rau A; Schwabenland M; Thurow J; Wagner D; Waller C; Niesen WD; Frings L; Urbach H; Prinz M; Weiller C; Schroeter N; Meyer PT
Brain; 2021 May; 144(4):1263-1276. PubMed ID: 33822001
[TBL] [Abstract][Full Text] [Related]
7. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results.
Pirker-Kees A; Platho-Elwischger K; Hafner S; Redlich K; Baumgartner C
Dement Geriatr Cogn Disord; 2021; 50(1):68-73. PubMed ID: 33853062
[TBL] [Abstract][Full Text] [Related]
8. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.
Zhou Y; Xu J; Hou Y; Leverenz JB; Kallianpur A; Mehra R; Liu Y; Yu H; Pieper AA; Jehi L; Cheng F
Alzheimers Res Ther; 2021 Jun; 13(1):110. PubMed ID: 34108016
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
[TBL] [Abstract][Full Text] [Related]
10. [Neuropsychiatric symptoms in people living with dementia related to COVID-19 pandemic lockdown. Exploratory systematic review].
Sánchez-García M; Rodríguez-Del Rey T; Pérez-Sáez E; Gay-Puente FJ
Rev Neurol; 2022 Feb; 74(3):83-92. PubMed ID: 35084733
[TBL] [Abstract][Full Text] [Related]
11. Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).
Aiello EN; Fiabane E; Manera MR; Radici A; Grossi F; Ottonello M; Pain D; Pistarini C
Neurol Sci; 2022 Jan; 43(1):81-84. PubMed ID: 34668124
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cognitive deficits in patients infected with COVID-19.
Arica-Polat BS; Gündoğdu AA; Cinar N; Uncu G; Ayas ZO; Iseri P; Karadas O; Adapinar DO
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):678-685. PubMed ID: 35113443
[TBL] [Abstract][Full Text] [Related]
13. Measuring the cognitive costs of the COVID-19 pandemic.
Day GS
Mol Neurodegener; 2021 Sep; 16(1):67. PubMed ID: 34556131
[No Abstract] [Full Text] [Related]
14. Episodic long-term memory in post-infectious SARS-CoV-2 patients.
Aiello EN; Fiabane E; Manera MR; Radici A; Grossi F; Ottonello M; Vassallo C; Pain D; Pistarini C
Neurol Sci; 2022 Feb; 43(2):785-788. PubMed ID: 34791568
[TBL] [Abstract][Full Text] [Related]
15. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
[TBL] [Abstract][Full Text] [Related]
16. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
Mao L; Jin H; Wang M; Hu Y; Chen S; He Q; Chang J; Hong C; Zhou Y; Wang D; Miao X; Li Y; Hu B
JAMA Neurol; 2020 Jun; 77(6):683-690. PubMed ID: 32275288
[TBL] [Abstract][Full Text] [Related]
17. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Rejdak K; Grieb P
Mult Scler Relat Disord; 2020 Jul; 42():102163. PubMed ID: 32388458
[TBL] [Abstract][Full Text] [Related]
18. Potential for Cognitive Communication Impairment in COVID-19 Survivors: A Call to Action for Speech-Language Pathologists.
Ramage AE
Am J Speech Lang Pathol; 2020 Nov; 29(4):1821-1832. PubMed ID: 32946270
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.
Alonso-Lana S; Marquié M; Ruiz A; Boada M
Front Aging Neurosci; 2020; 12():588872. PubMed ID: 33192483
[TBL] [Abstract][Full Text] [Related]
20. Neurological and cognitive sequelae of Covid-19: a four month follow-up.
Mattioli F; Stampatori C; Righetti F; Sala E; Tomasi C; De Palma G
J Neurol; 2021 Dec; 268(12):4422-4428. PubMed ID: 33932157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
